Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy

被引：164

作者：

Cheok, MH

Evans, WE

机构：

[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA

[2] Univ Tennessee, Memphis, TN 38105 USA

来源：

NATURE REVIEWS CANCER | 2006年 / 6卷 / 02期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nrc1800

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The use of combination chemotherapy to cure acute lymphoblastic leukaemia (ALL) in children emerged in the 1980s as a paradigm for curing any disseminated cancer, and many of the therapeutic principles were subsequently applied to the treatment of other disseminated human cancers. Similarly, elucidation of the pharmacogenomics of ALL and its translation into new chemotherapeutic approaches might serve as a model for optimizing the treatment of other human cancers. Germline polymorphisms and gene-expression patterns in ALL cells have been linked to the toxicity and efficacy of chemotherapy for ALL and are beginning to emerge as useful clinical diagnostics.

引用

收藏

页码：117 / 129

页数：13

相关论文

共 118 条

[71] Acute lymphoblastic leukemia [J].

Pui, CH ;

Evans, WE .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :605-615

[72] Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia [J].

Qian, ZJ ;

Fernald, AA ;

Godley, LA ;

Larson, RA ;

Le Beau, MM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) :14925-14930

[73] DNA microarrays in clinical oncology [J].

Ramaswamy, S ;

Golub, TR .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1932-1941

[74] Pharmacogenetics and cancer therapy [J].

Relling, MV ;

Dervieux, T .

NATURE REVIEWS CANCER, 2001, 1 (02) :99-108

[75] Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia [J].

Relling, MV ;

Yanishevski, Y ;

Nemec, J ;

Evans, WE ;

Boyett, JM ;

Behm, FG ;

Pui, CH .

LEUKEMIA, 1998, 12 (03) :346-352

[76]

Relling MV, 1999, BLOOD, V93, P2817

[77] Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus [J].

Relling, MV ;

Hancock, ML ;

Rivera, GK ;

Sandlund, JT ;

Ribeiro, RC ;

Krynetski, EY ;

Pui, CH ;

Evans, WE .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (23) :2001-2008

[78] High incidence of secondary brain tumours after radiotherapy and antimetabolites [J].

Relling, MV ;

Rubnitz, JE ;

Rivera, GK ;

Boyett, JM ;

Hancock, ML ;

Felix, CA ;

Kun, LE ;

Walter, AW ;

Evans, WE ;

Pui, CH .

LANCET, 1999, 354 (9172) :34-39

[79] Pharmacogenetics of outcome in children with acute lymphoblastic leukemia [J].

Rocha, JCC ;

Cheng, C ;

Liu, W ;

Kishi, S ;

Das, S ;

Cook, EH ;

Sandlund, JT ;

Rubnitz, J ;

Ribeiro, R ;

Campana, D ;

Pui, CH ;

Evans, WE ;

Relling, MV .

BLOOD, 2005, 105 (12) :4752-4758

[80] An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas [J].

Roepman, P ;

Wessels, LFA ;

Kettelarij, N ;

Kemmeren, P ;

Miles, AJ ;

Lijnzaad, P ;

Tilanus, MGJ ;

Koole, R ;

Hordijk, GJ ;

van der Vliet, PC ;

Reinders, MJT ;

Slootweg, PJ ;

Holstege, FCP .

NATURE GENETICS, 2005, 37 (02) :182-186

← 3 4 5 6 7 8 9 10 11 12 →